Related Experiment Videos
Sphingolipids in adipose tissue: What's tipping the scale?
Johana M Lambert1, Andrea K Anderson1, L Ashley Cowart2
1Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Advances in Biological Regulation
|November 27, 2018
Summary
Sphingolipids significantly impact adipose tissue function and dysfunction, influencing obesity and metabolic syndrome. This review explores their roles in fat cell development, metabolism, and inflammation.
Area of Science:
- Metabolic research
- Endocrinology
- Obesity research
Background:
- Adipose tissue is central to obesity, acting as an endocrine organ secreting adipokines.
- Sphingolipids are bioactive molecules implicated in metabolic syndrome and obesity-related diseases.
- The specific roles of sphingolipids within adipose tissue require further investigation.
Purpose of the Study:
- To review the multifaceted effects of sphingolipids on adipose tissue function and dysfunction.
- To highlight the connection between sphingolipids and key metabolic processes within adipocytes.
Main Methods:
- Literature review of existing research on sphingolipids and adipose tissue.
- Synthesis of findings related to adipogenesis, metabolism, thermogenesis, inflammation, and insulin resistance.
Main Results:
- Sphingolipids modulate adipogenesis (fat cell differentiation) and lipid metabolism.
- These molecules influence energy expenditure through thermogenesis.
- Sphingolipids play a critical role in adipose tissue inflammation and the development of insulin resistance.
Conclusions:
- Sphingolipids are key regulators of adipose tissue homeostasis and metabolic health.
- Dysregulation of sphingolipid metabolism in adipose tissue contributes to obesity and metabolic syndrome.
- Targeting sphingolipid pathways in adipose tissue may offer therapeutic strategies for metabolic diseases.